The role of CD4 in HIV envelope-mediated pathogenesis

Current Topics in Microbiology and Immunology

Volumn 205, Issue , 1996, Pages 159-179

  Siliciano, R F ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; APOPTOSIS; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; SYNCYTIUM; T LYMPHOCYTE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0029655470     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-79798-9_8     Document Type: Review

References (121)

1. + cell function down-regulation in AIDS patients. J Immunol 148 2709-2716
2. Asjo B, Ivhed I, Gidlund M, Fuerstenberg S, Fenyo EM, Nilsson K, Wigzell H (1987) Susceptibility to infection by the human immunodeficiency virus (HIV) correlates with T4 expression in a parental monocytoid cell line and its subclones Virology 157 359-365
3. Banda NK, Bernier J, Kurahara DK, Kurrie R, Haigwood N, Sekaly R-P, Finkel TH (1992) Cross-linking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis J Exp Med 176. 1099-1106
4. Bank I, Chess L (1985) Perturbation of the T4 molecule transmits a negative signal to T cells J Exp Med 162. 1294-1303
5. Bergeron L, Sodroski J (1992) Dissociation of unintegrated viral DNA accumulation from single-cell lysis induced by human immunodeficiency virus type 1. J Virol 66: 5777-5787
6. Boldt-Houle DM, Rinaldo CR Jr, Ehrlich GD (1993) Random depletion of T cells that bear specific T cell receptor V beta sequences in AIDS patients J Leukoc Biol 54: 486-491
7. Bolognesi DP, Langlois AJ, Schafer W (1975) Polypeptides of mammalian oncornaviruses IV. Structural components of murine leukemia virus released as soluble antigens in cell culture Virology 68. 550-555
8. Boyer V, Smith LR, Ferre F, Pezzoli P, Trauger RJ, Jensen FC, Carlo DJ (1993) T cell receptor V beta repertoire in HIV-infection individuals: tack of evidence for selective V beta deletion. Clin Exp Immunol 92: 437-441
9. Bozzette SA, McCutchan JA, Spector SA, Wright B, Richman DD (1993) A cross-sectional comparison of persons with syncytium- and non-syncytium-inducing human immunodeficiency virus J infect Dis 168: 1374-1379
10. Brenner BG, Gryllis C, Wainberg MA (1990) Role of antibody-dependent cellular cytotoxicity and lymphokine-activated killer cells in AIDS and related diseases J Leukoc Biol 50: 628-640
11. Bullough PA, Hughson FM, Skehel JJ, Wiley DC (1994) Structure of the influenza haemagglutinin at the pH of membrane fusion Nature 371 37-43
12. Callahan KM, Fort MM, Obah EA, Reinherz EL, Siliciano RF (1990) Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor. J Immunol 144: 3341-3346
13. Callahan KM, Rowell JF, Soloski MJ, Machamer CE, Siliciano RF (1993) HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes J Immunol 151: 2928-2942
14. Chen ZW, Kou ZC, Shen L, Reimann KA, Letvin NL (1993) Conserved T-cell receptor repertoire in simian immunodeficiency virus-infected rhesus monkeys. J Immunol 151: 2177-2187
15. Cheng-Mayer C, Seto D, Tateno M, Levy JA (1988) Biological features of HIV-1 that correlate with virulence in the host Science 240: 80-82
16. Chirmule N, Kalyanaraman V, Oyaizu N, Pahwa S (1988) Inhibitory influences of envelope glycoproteins of HIV-1 on normal immune responses. J Acquir Immune Defic Syndr 1, 425-430
17. Chirmule N, Kalyanaraman VS, Oyaizu N, Slade HB, Pahwa S (1990) Inhibition of functional properties of tetanus antigen-specific T-cell clones by envelope glycoprotein gp120 of human immunodeficiency virus. Blood 75. 152-159
18. Clayton LK, Sieh M, Pious DA, Reinherz EL (1989) Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding Nature 339: 548-551
19. lck complex in the endoplasmic reticuium. J Virol 66: 2296-2301
20. Crise B, Buonocore L, Rose JK (1990) CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor. J Virol 64: 5585-5593
21. + human immunodeficiency virus type 1 (HIV-1) envelope-specific cytotoxic T lymphocytes derived from the peripheral blood cells of an HIV-1-infected individual. AIDS Res Hum Retroviruses 9: 61-68
22. Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312: 763-767
23. + cells. Vox Sang 64 31-36
24. Daniel V, Susal C, Weimer R, Zimmermann R, Huth-Kuhne A, Opelz G (1993b) Association of T cell and macrophage dysfunction with surface gp120-immunoglobulin-complement complexes in HIV-infected patients. Clin Exp Immunol 93 152-156
25. Earl PL, Doms RW, Moss B (1990) Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein Proc Natl Acad Sci USA 87: 648-652
26. Fenyo EM, Morfeldt-Manson L, Chiodi F, Lind B, von Gegerfelt A, Albert J, Olausson E, Asjo B (1988) Distinctive replicative and cytopathic characteristics of human immunodeficiency virus isolates J Virol 62: 4414-4419
27. Fisher AG, Ensoli B, Looney D, Rose A, Gallo RC, Saag MS, Shaw GM, Hahn BH, Wong-Staal F (1988) Biologically diverse molecular variants within a single HIV-1 isolate. Nature 334. 444-447
28. Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M (1986) The role of mononuclear phagocytes in HTLV-III/LAV infection Science 233 215-219
29. Gelderblom HR, Reupke H, Pauli G (1985) Loss of envelope antigens of HTLV-III/LAV, a factor in AIDS pathogenesis Lancet 2 1016-1017
30. Gelderblom HR, Hausmann EHS, Ozel M, Pauh G, Koch MA (1987) The structure of human immunodeficiency vsrus (HIV) and immunolocalization of structural proteins Virology 156: 171-176
31. + lymphocytes in vivo. J Immunol 138: 3725-3730
32. Gougeon ML, Garcia S, Heeney J, Tschopp R, Lecoeur H, Guetard D, Rame V, Dauguet C, Montagnier L (1993) Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retroviruses 9 553-563
33. +T cells from human immunodeficiency virus-infected asymptomatic individuals J Exp Med 175: 331-340
34. + lymphocyte function with early human immunodeficiency virus infection Proc Natl Acad Sci USA 86 1993-1997
35. Habeshaw JA, Dalgleish AG, Bountiff L, Newell AL, Wilks D, Walker LC, Manca F (1990) AIDS pathogenesis: HIV envelope and its interaction with cell proteins. Immunol Today 11. 418-425
36. Hammond SA, Obah E, Stanhope P, Monell CR, Strand M, Robbins FM, Bias WB, Karr RW, Koenig S, Siliciano RF (1991) Characterization of a conserved T cell epitope in HIV-1 gp41 recognized by vaccine-induced human cytolytic T cells. J Immunol 146: 1470-1477
37. + cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines. J Exp Med 176: 1531-1542
38. Harper ME, Marselle LM, Gallo RC, Wong-Staal F (1986) Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc Natl Acad Sci USA 83: 772-776
39. Hildreth JE, Orentas RJ (1989) Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation Science 244: 1075-1078
40. Ho DD, Rota TR, Hirsh MS (1986) Infection of monocyte/macrophages by human T lymphotropic virus type III. J Clin Invest 77. 1712-1720
41. Horak ID, Popovik M, Horak EM, Lucas PJ, Gress RE, June CH, Bolen JB (1990) No T-cell tyrosine protein kinase signaling or calcium mobilization after CD4 association with HIV-1 or HIV-1 gp120. Nature 348; 557-560
42. Hoxie JA, Alpers JD, Rackowski JL, Huebner K, Haggarty BS, Cedarbaum AJ, Reed JC (1986) Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. Science 234 1123-1127
43. Imberti L, Sottini A, Bettinardi A, Puoti M, Primi D (1991) Selective depletion in HIV infection of T cells that bear specific T cell receptor V beta sequences. Science 254: 860-862
44. Johnson RP, Hammond SA, Trocha A, Siliciano RF, Walker BD (1994) Induction of a MHC class 1-restricted cytotoxtc T lymphocyte response to a highly conserved region of HIV-1 gp120 in seronegative humans immunized with a candidate HIV-1 vaccine. J Virol 68 3145-3153
45. Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T Gluckman JC, Montagnier L (1984) T-lymphocyte T4 molecule behaves as the receptor for the human retrovirus LAV. Nature 312: 767-768
46. Koenig S, Fauci AS (1988) Immunopathogenesis and immune response to human immunodeficiency virus. In DeVita V, Hellman S, Rosenberg SA (eds) AIDS Lippincott, Philadelphia
47. + human cell lines. J Virol 64 4661-4671
48. Koga Y, Sasaki M, Yoshida H, Wigzell H, Kimura G, Nomoto K (1990b) Cytopathic effect determined by the amount of CD4 molecules in human cell lines expressing envelope glycoprotein of HIV. J Immunol 144: 94-102
49. + cells expressing gp160 of human immunodeficiency virus. J Virol 65: 5609-5612
50. Koga Y, Nakamura K, Sasaki M, Kimura G, Nomoto K (1994) The difference in gp160 and gp120 of HIV type 1 in the induction of CD4 downregutation preceding single-cell killing. Virology 201 137-141
51. + cell depletion and progression to AIDS. Ann Intern Med 118: 681-688
52. Kornfeld H, Cruikshank WW, Pyle SW, Berman JS, Center DM (1988) Lymphocyte activation by HIV-1 envelope glycoprotein. Nature 335: 445-448
53. Kowalski M, Bereron L, Dorfman T, Haseltine W, Sodroski W (1991) Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein. J Virol 65: 281-291
54. Krowka J, Stites D, Mills J, Hollander H, McHugh T, Busch M, Wilhelm L, Blackwood L (1988) Effects of interleukin 2 and large envelope glycoprotein (gp120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses to cytomegalovirus. Clin Exp Immunol 72: 179-185
55. + cytotoxic T-lymphocytes [published erratum appears in AIDS (1992) 6(9). following 1051]. AIDS 6: 643-649
56. + cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine. Proc Natl Acad Sci USA 89: 11204-11208
57. Landau NR, Warton M, Littman DR (1988) The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4. Nature 334: 159-162
58. Lane HC, Depper JM, Greene WC, Whalen G, Waldmann TA, Fauci (1985) Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome: evidence for a selective defect in soluble antigen recognition. N Engl J Med 313: 79-84
59. Lanzavecchia A, Roosnek E, Gregory T, Berman P, Abrignani S (1988) T cells can present antigens such as HIV gp120 targeted to their own surface molecules. Nature 334: 530-532
60. Lasky LA, Nakamura G, Smith DH, Fennie C, Shimasaki C, Patzer E, Berman P, Gregory T, Capon DJ (1987) Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 50: 975-985
61. Laurence J, Hodtsev AS, Posnett DN (1992) Superantigen implicated in dependence of HIV-1 replication in T cells on TCR V beta expression. Nature 358. 255-259
62. Laurent-Crawford AG, Hovanessian AG (1993) The cytopathic effect of human immunodeficiency virus is independent of high levels of unintegrated viral DNA accumulated in response to superinfection of cells. J Gen Virol 74. 2619-2628
63. Laurent-Crawford AG, Krust B, Muller S, Riviere Y, Rey-Cuille MA, Bechet JM, Montagnier L, Hovanessian AG (1991) The cytopathic effect of HIV is associated with apoptosis. Virology 185: 829-839
64. Layne SP, Merges MJ, Dembo M, Spouge JL, Conley SR, Moore JP, Raina JL, Renz H, Gelderblom HR, Nara PL (1992) Factors underlying the spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 189: 695-714
65. Liegler TJ, Stites DP (1994) HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness in peripheral CD4 T lymphocytes J Acquir Immune Defic Syndr 7: 340-348
66. Lifson JD, Feinberg MB, Reyes GR, Rabin L, Banapour B, Chakrabarti S, Moss B, Wong-Staal F, Steimer KS, Engleman EG (1986a) Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein Nature 323 725-728
67. Lifson JD, Reyes GR, McGrath MS, Stein BS, Engleman EG (1986b) AIDS retrovirus induced cytopathology giant cell formation and involvement of CD4 antigen. Science 232 1123-1127
68. + cytotoxic T-lymphocyte clone to a conserved epitope on human immunodeficiency virus Type 1 p24, cytotoxic activity and secretion of interleukin-2 and interleukin-6 J Virol 66 608-611
69. + cells expressing gp160 of human immunodeficiency virus type 1 J Virol 68 390-399
70. Lyerly HK, Matthews TJ, Langlois AJ, Bolognesi DP, Weinhold KJ (1987) Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells as a target for immune attack Proc Natl Acad Sci USA 84: 4601-4605
71. Macher AM, De Vinatea ML, Angritt P, Tuur SM, Reichert CM (1988) Pathological features of patients infected with human immunodeficiency virus. In: DeVita D, Hellman S, Rosenberg SA (eds) AIDS Lippincott, Philadelphia, pp 155-184
72. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R (1986) The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain Cell 47: 333-348
73. Manca F, Habeshaw JA, Dalgleish AG (1990) HIV envelope glycoprotein, antigen specific T-cell responses, and soluble CD4 Lancet 335 811-815
74. Mann DL, Lasane F, Popovic M, Arthur LO, Robey WG, Blattner WA, Newman MJ (1987) HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis J Immunol 138: 2640-2644
75. + T cell in vitro Differential induction of apoptosis in these cells J Immunol 152. 330-342
76. McCune JM, Rabin LB, Feinberg MB, Lieberman M, Kosek JC, Reyes GR, Weissman IL (1988) Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell 53 55-67
77. + T cells by a complex of the 110K viral protein and the T4 molecule. Science 231: 382-385
78. McDougal JS, Nicholson JK, Cross GD, Cort SP, Kennedy MS, Mawle AC (1986b) Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry. J Immunol 137. 2937-2944
79. McKeating JA, McKnight A, Moore JP (1991) Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: Effects on infectivity and neutralization. J Virol 65, 852-860
80. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RPM, Miedema F (1992) Programmed cell death of T cells in HIV-1 infection. Science 257: 217-219
81. Meyaard L, Otto SA, Keet IP, Roos MT, Miedema F (1994) Programmed death of T cells in human immunodeficiency virus infection. No correlation with progression to disease, J Clin Invest 93: 982-988
82. + human CTL induced by candidate AIDS vaccines. J Immunol 152: 2787-2799
83. Mittler RS, Hoffmann MK (1989) Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation. Science 245: 1380-1382
84. Moore JP, McKeating JA, Weiss RA, Sattentau QJ (1990) Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 250: 1139-1142
85. Moore MW, Carbone FW, Bevan MJ (1988) Introduction of soluble antigen into the class I pathway of antigen processing and presentation. Cell 54. 777-786
86. Morrison LA, Lukacher A, Braciale VL, Fan DP, Braciale TP (1986) Differences in antigen presentation to MHC class 1 and class II-restricted influenza virus specific cytolytic T lymphocyte clones. J Exp Med 163: 903-913
87. Newell MK, Haughn LJ, Maroun CR, Julius MH (1990) Death of mature T cells by separate ligation of CD4 and the T-cell antigen receptor. Nature 347: 286-289
88. Nicloson JKA, Gross GD, Callaway CS, McDougal JS (1986) In vitro infection of human monocytes with T lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). J Immunol 137: 323-329
89. Oh S-K, Cruishank WW, Raina J, Blanchard GC, Adler WH, Walker J, Kornfeld H (1992) Identification of HIV-1 envelope glycoproteins in the serum of AIDS and ARC patients J Acquir Immune Defic Syndr 5. 251-256
90. Orentas RJ, Hildreth JE, Obah E, Polydefkis M, Smith GE, Clements ML, Siliciano RF (1990) Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine. Science 248 1234-1237
91. + T cell recognition. J Exp Med 171: 875-887
92. Posnett DN, Kabak S, Hodtsev AS, Goldberg EA, Asch A (1993) T-cell antigen receptor V beta subsets are not preferentially deleted in AIDS AIDS 7: 625-631
93. Richman DD, Bozzette SA (1994) The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J Infect Dis 169: 968-974
94. Rosenstein Y, Burakoff SJ, Herrmann SH (1994) HIV-gp120 can block CD4-class II MHC-mediated adhesion. J Immunol 144; 526-531
95. Salahuddin SZ, Rose RM, Groopman JE, Markham PD, Gallo RC (1986) Human T lymphotropic virus type III infection of human alveolar macrophages. Blood 68: 281-284
96. Schneider J, Kaaden O, Copeland TD, Oroszlan S, Hunsmann G (1986) Shedding and interspecies type seo-reactivrty of the envelope glycopolypeptide gp120 of the human immunodeficiency virus. J Gen Virol 67. 2533-2538
97. Schnittman S, Lane HC, Roth J, Burrows A, Folks T, Kehri J, Koenig S, Berman P, Fauci A (1988) Characterization of gp120 binding of CD4 and an assay that measures ability of sera to inhibit this binding. J Immunol 141. 4181-4186
98. Schwartz S, Felber BK, Fenyo EM, Pavlakis GN (1990) Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs J Virol 64: 5448-5456
99. Shalaby MR, Krowka JF, Gregory TJ, Hirabayashi SE, McCabe SM, Kaufman DS, Stites DP, Ammann AJ (1987) The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitro. Cell Immunol 110: 140-148
100. Shearer GM, Bernstein DC, Tung KSK, Via CS, Redfield R, Salahuddin SZ, Gallo RC (1986) A model for the selective loss of major histocompatibitity complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J Immunol 137: 2514-2521
101. + cell depletion. Cell 54: 561-575
102. Siliciano RF, Knall C, Karr RC, Berman P, Gregory T, Reinherz EL (1989) Recognition of human immunodeficiency virus (HIV) glycoprotein gp120 by T cells: role of monocyte CD4 in the presentation of gp120 J Immunol 142. 1506-1511
103. Sodroski J, Goh WC, Rosen C, Campbell K, Haseltine WA (1986) Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity nature 322: 470-474
104. Somasundaran M, Robinson HL (1987) A major mechanism of human immunodeficiency virus-induced cell killing does not involve cell fusion J Virol 61 3114-3119
105. + cytolytic T lymphocyte responses to a human immunodeficiency virus type 1 gp160 subunit vaccine. J Infect Dis 168: 92-100
106. + T cell response that includes cytolytic T lymphocytes. J Immunol 150 4672-4686
107. + cells: mechanism for persistence in AIDS Cell 53: 483-496
108. Stevenson M, Haggerty S, Lamonica C, Mann AM, Meier C, Wasiak A (1990) Cloning and characterization of human immunodeficiency virus type 1 variants diminished in the ability to induce syncytium-independent cytolysis. J Virol 64: 3792-3803
109. Terai C, Kornbluth RS, Pauza CD, Richman DD, Carson DA (1991) Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 87: 1710-1715
110. Tersmette M, Gruters RA, de Wolf F, de Goede RE, Lange JM, Schellekens PT, Goudsmit J, Huisman HG, Miedema F (1989) Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates J Virol 63: 2118-2125
111. Thali M, Olshevsky U, Furman C, Gabuzda D, Posner M, Sodroski J (1991) Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody. J Virol 65 6188-6193
112. + effector cells armed in vivo with cytophilic antibody J Immunol 142. 1177-1182
113. Tyler DS, Stanley SD, Natala CA, Austin AA, Bartlett JA, Stine KC, Lyerly HK, Bolognesi DP, Weinhold KJ (1990) Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection Humoral and cellular defects. J Immunol 144 3375-3384
114. van Noesel CJM, Gruters RA, Terpstra FG, Schellekens PTA, van Lier RAW, Miedema F (1994) Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men J Clin Invest 86: 293-299
115. Walker BD, Plata F (1990) Cytotoxic T lymphocytes against HIV (review) AIDS 4. 177-184
116. Weinhold KJ, Lyerly HK, Stanley SD, Austin AA, Matthews TJ, Bolognesi DP (1989) HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection J Immunol 142 3091-3097
117. White J, Kielian M, Helenius A (1983) Membrane fusion proteins of enveloped animal viruses Q Rev Biophys 16. 151-195
118. Willey RL, Bonifacino JS, Potts BJ, Martin MA, Klausner RD (1988) Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160 Proc Natl Acad Sci USA 85. 9580-9584
119. Willey RL, Maldarelli F, Martin MA, Strebel K (1992a) Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J Virol 66: 226-234
120. Willey RL, Maldarelli F, Martin MA, Strebel K (1992b) Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4 J Virol 66 7193-7200
121. York-Higgins D, Chang-Mayer C, Bauer D, Levy JA, Dina D (1990) Human immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genome J Virol 64 4016-4020